Experiments for taxon Cryptolepis sanguinolenta (ASCLEPIADACEAE)

479 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
370428	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
922696	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370445	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
508296	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370439	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
356166	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-CARBOXY:
597861	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
496317	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
179901	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
507173	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
537787	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
1290249	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
949922	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
674023	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
346769	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508316	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
356155	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
610740	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508349	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
669137	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346779	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
197808	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOSANGUINOLENTINE
597853	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
597850	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
446462	PHARMACOLOGY OF COMPOUND - IN VITRO	INOTROPIC EFFECT NEGATIVE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
1014553	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN SYNTHETASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
370417	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
250002	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
713580	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
508330	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
346783	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346801	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
746826	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346812	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
380067	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
374483	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
386038	PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508327	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
346806	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
787763	PHARMACOLOGY OF EXTRACT - IN VIVO	WEIGHT LOSS	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346772	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508305	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
674027	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
147570	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATATLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
249980	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID
507176	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346794	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
356160	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-CARBOXY:
987738	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356144	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
523856	CRUDE DRUG DESCRIPTIONMICROSCOPY OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380056	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
187044	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINONE
674016	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
380062	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
674024	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
374482	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
249992	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
380053	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
379239	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
775802	PHYTOCHEMICAL SCREENING FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	O
927738	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346816	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
370444	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
346802	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
346782	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
380093	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
811238	VOUCHER SPECIMEN REPORTED FORYIELD IS MORE THAN 100 MGMQUANTITATIVE DATASEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPIS SANGUINOLENTA COMPOUND CSA-3
370433	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
346819	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508320	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508309	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
249984	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID METHYL ESTER
187043	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOTACKIENE
346807	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
496325	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508341	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
178319	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINECRYPTOSPIROLEPINEQUINDOLINE
949927	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
446455	PHARMACOLOGY OF EXTRACT - IN VITRO	MUSCARINIC ANTAGONIST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
557521	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
187040	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,ISO:
380086	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
178317	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPICARBOLINE
507169	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
1023354	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380075	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
229774	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-ISO-PROPYL:
565259	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370435	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
496318	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
713576	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380064	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
346822	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380051	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
346827	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
173889	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
446461	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC ANTAGONIST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380078	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
557519	MEDICINAL FOLKLORE REPORTED FOR	ANTIPYRETIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370411	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508338	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
508331	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
987737	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370440	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
906484	MEDICINAL FOLKLORE REPORTED FOR	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
922695	MEDICINAL FOLKLORE REPORTED FOR	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
597857	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,ISO:
380089	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
370422	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
179904	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
380084	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
147569	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380073	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
187039	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINONE
949924	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
507170	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
1290248	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
597852	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
379243	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSE UPTAKE INDUCTION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
523857	CRUDE DRUG DESCRIPTIONMICROSCOPY OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370430	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
1023356	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508334	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
370415	PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
1014549	PRESENT IN (REVIEW)PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
249995	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346768	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
374484	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSE TRANSPORT STIMULATION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346811	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
537786	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508301	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370426	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
249998	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380080	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
356140	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
674032	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
1076797	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
610741	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	HYPOLIPEMIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
249981	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID
346793	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
183684	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
356162	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-CARBOXY:
249991	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
356149	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
386039	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINEQUINDOLINE
380057	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
370441	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
674020	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
674019	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346771	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508315	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346825	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
610737	PATENT DESCRIBED		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
1014554	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN SYNTHETASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
446454	PHARMACOLOGY OF EXTRACT - IN VITRO	MUSCARINIC ANTAGONIST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
746824	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
992652	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356151	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
370437	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346803	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
871324	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508348	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
250001	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
775801	PHYTOCHEMICAL SCREENING FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	O
746825	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
597849	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
249985	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID METHYL ESTER
557520	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
173888	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,ISO:
508310	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380068	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
356145	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380087	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
511257	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346826	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380090	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
346775	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508319	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
370438	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508323	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508299	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
496324	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
187042	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE,11-METHOXY:
507179	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
31074	PRESENT IN (REVIEW)		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
1014550	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
370412	PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346786	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508337	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
44674	PRESENT IN (REVIEW)PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERTENSIVE ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380076	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
346790	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
922693	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356152	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
597848	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508304	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
713577	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
597856	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
370423	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356163	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-CARBOXY:
356139	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
187046	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
379240	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
787760	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356148	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
346770	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356141	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508326	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
380072	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
380094	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
187038	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOMISRINE
370434	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
380061	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
496328	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
179905	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
380054	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
508342	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
949926	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346815	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
597851	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
507175	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380083	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
508312	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508345	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
356159	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINECRYPTOLEPINE,11-CARBOXY:CRYPTOLEPINE,11-METHYL-CARBOXY:CRYPTOLEPINE,HYDROXY:QUINDOLINE
532255	STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINONE
346781	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
987736	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370416	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380049	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
249979	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID
507168	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
1023353	PRESENT IN (REVIEW)PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380065	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
1219481	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370427	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
674025	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508308	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508321	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
356156	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346797	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
380079	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
380050	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
226851	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508318	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508322	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
1290250	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508307	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370414	PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508335	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
249986	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID METHYL ESTER
508311	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
249988	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
250004	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356142	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380058	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
597855	PHARMACOLOGY OF COMPOUND - IN VIVO	CELL CYCLE CYTOTOXICITY(G1 PHASE)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
249997	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
446458	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346798	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
1023357	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508332	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
775800	PHYTOCHEMICAL SCREENING FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	O
1290381	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
557517	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380069	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
496319	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
507171	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
179903	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
370436	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
374485	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
523007	UV SPECTRUM GIVEN FORPRESENT IN (REVIEW)MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346799	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
557516	PRESENT IN (REVIEW)		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
674021	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
674031	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
811236	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
610742	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
249982	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID METHYL ESTER
610738	PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
523934	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
496327	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346777	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346792	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
370425	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
597859	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,ISO:
674029	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
370419	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508302	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
496316	MEDICINAL FOLKLORE REPORTED FOR	ASTRINGENT EFFECT	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
173890	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508300	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
597860	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,ISO:
508329	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
346804	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
674018	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
370431	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
356153	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
597847	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
992651	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370420	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346796	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
356138	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINECRYPTOLEPINE,HYDROXY:QUINDOLINE
496323	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
669135	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346787	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
511258	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508346	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
346776	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380071	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
147567	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOSPIROLEPINE
380077	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
379242	PHARMACOLOGY OF COMPOUND - IN VIVO	INSULIN LEVEL DECREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
496320	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
674026	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
713578	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
346824	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
1006112	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508298	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346785	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
356164	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-CARBOXY:
507178	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
446459	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC ANTAGONIST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346767	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346814	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
346788	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508313	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
386040	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
380091	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
370442	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
523008	UV SPECTRUM GIVEN FORPRESENT IN (REVIEW)PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346809	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
922694	MEDICINAL FOLKLORE REPORTED FOR	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
906482	MEDICINAL FOLKLORE REPORTED FOR	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356157	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
906485	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370418	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
787761	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508343	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
1014552	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
1014551	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380088	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
356146	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
44673	MEDICINAL FOLKLORE REPORTED FOR	CNS STIMULANT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
197809	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOTACKIEINE
226852	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTED		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINONE
523933	MEDICINAL FOLKLORE REPORTED FOR	ANTIPYRETIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
187037	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
507167	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380066	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
250000	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
249989	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380060	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
775799	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIAMEBIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508324	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
183686	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
380055	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
249994	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
674017	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
507174	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
374481	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346780	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
380095	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
674015	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
346774	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
179902	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
557518	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
1318473	MEDICINAL FOLKLORE REPORTED FOR	ANALGESIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346805	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
674030	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
370429	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
949925	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
446457	PHARMACOLOGY OF EXTRACT - IN VITRO	INOTROPIC EFFECT NEGATIVE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
610743	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508306	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356154	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
922697	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
713575	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
249987	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
356161	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-CARBOXY:
507172	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
250003	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
674028	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
179071	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINONE,HOMO:
597854	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380059	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
508328	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
386037	VOUCHER SPECIMEN REPORTED FORPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
610739	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346800	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
508297	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508325	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
346820	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508344	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
346813	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
508314	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
370424	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356150	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
508303	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
964325	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
187045	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOSPIROLEPINE
508339	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
380082	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
249996	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
713579	ISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
1290251	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
987740	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
249983	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINOIC ACID METHYL ESTER
346791	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
507177	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
565260	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIVIRAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
987739	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346778	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
557522	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
597858	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,ISO:
356143	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
301748	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPOUND ISOLATED HAS UNUSUAL NAME		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINOCRYPTOTACKIEINE
949923	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
379241	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
147568	MEDICINAL FOLKLORE REPORTED FOR	ANTIPYRETIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508317	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
496321	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
1023358	PHARMACOLOGY OF COMPOUND - IN VITRO	SMOOTH MUSCLE RELAXANT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
992653	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346818	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
370413	PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
669136	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
496326	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
508336	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
178318	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346817	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346766	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
187041	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPICARBOLINE
380081	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
446456	PHARMACOLOGY OF EXTRACT - IN VITRO	MUSCARINIC ANTAGONIST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
508347	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOHEPTINE
346789	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
1023355	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380074	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
346821	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
811237	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
380063	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
370421	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
379238	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346795	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
183685	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINOLINE
787762	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380085	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
511259	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIYEAST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
356147	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
249990	IDENTIFICATION IN BY HPLC		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
380070	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
380092	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
346773	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
496322	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346823	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346784	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
380052	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
44675	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOTHERMIC ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346765	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
346808	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
356158	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
507166	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIVIRAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
906483	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)
380048	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
356165	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-CARBOXY:
446460	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC ANTAGONIST ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346828	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICOMPLEMENT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
346810	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE HCL
249999	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
775798	VOUCHER SPECIMEN REPORTED FOR		Cryptolepis sanguinolenta (ASCLEPIADACEAE)
370443	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
674022	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
370432	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
508333	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,HYDROXY:
1006111	PRESENT IN (REVIEW)PHARMACOLOGY OF COMPOUND - IN VITRO	SMOOTH MUSCLE STIMULANT ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
249993	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
508340	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE

Experiments for taxon Cryptolepis sanguinolenta (ASCLEPIADACEAE)

Experiments (479 results)

Filters

Worktypes (29)

Pharmacology (35)

Compounds (32)

Organisms (71)